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Summary: A simple one-vial-method was developed for the quantitative determination of Sphingomyelinase activity
in human leukocytes and urine, using [14C-inethyl] sphingomyelin. The measured activities of healthy control persons
show a higher scatter in (n=50) urine (1.2 ± 0.5 nmol/h - ml urine) than in (n=9) leukocytes (2.15 ± 0.35 nmol/h - mg
protein). Long term tests showed that the enzyme activities in urine can best be correlated to the 24-h-creatinine
excretion. A distinct loss of enzyme activity was found in dialyzed urine starting at about the third day; this did not
occur in undialyzed urine. The method also shows good reproducibility in micro-tests. It is therefore suitable for
screening tests (urine of persons suffering fiomNiemann-Pick disease) and for the prenatal diagnosis of sphingo-
myelinosis.
" For one out of two children with symptoms of sphingomyelinosis (hepatosplenomegaly, mental retardation, and
neurological deterioration) the diagnosis was confirmed by morphological examination of tissues obtained by biopsy.
In both cases leukocytes and urine revealed normal Sphingomyelinase activity. These biochemical results in conjunct-
ion with the clinical and morphological picture were indicative of type C Niemann-Pick disease.
Eine Mikromethode zur Bestimmung von Sphingomyelinase in Leukocyten und Urin
Zusammenfassung: Eine leicht durchführbare Methode zur quantitativen Bestimmung der Sphingomyelinaseaktivität
in Leukocyten und Urin wird vorgestellt. Als Substrat dient das käufliche [14C-Methyl] Sphingomyelin. Die im Urin
(n=50) gemessene Enzymaktivität gesunder Versuchspersonen weist mit l ,2 ± 0,5 nmol/h · ml Urin, verglichen mit
den Werten für Leukocytenprotein (n=9) mit 2,15 ± 0,35 nmol/h - mg Protein, eine größere Streuung um den Mittel-
wert auf.
In einem Langzeitversuch über drei Wochen konnte gezeigt werden, daß sich die täglich im Urin ermittelten Enzym-
aktivitäten am engsten zur 24-Stunderi-Kreatininausscheidung korrelieren lassen. Am dialysierten Urin trat etwa ab
dem dritten Tag ein deutlicher Enzymäktivitätsverlüst gegenüber undialysiertem Urin auf.
Wegen der Zuverlässigkeit der Methode gerade im Mikrobereich eignet sie sich für klinisch-diagnostische Zwecke
(Screening-Untersuchungen und pränatale Diagnostik der Sphingomyelinosen).
Zwei Kinder wiesen etwa ab dem dritten Lebensjahr zunehmend Symptome (Hepatosplenomegalie, geistiger Ent-
wicklungsrückstand und neurologische Störungen) auf, die an eine Lipidspeicherkrankheit denken ließen. Tatsäch-
lich wurde in dem einen untersuchten Fall die Diagnose einer Sphingomyelinose lichtmikroskopisch und elektronen-
optisch an Biopsiematerial gesichert. Die normale Sphingomyelinaseaktivität in Leukocyten und Urin erlaubte eine
Zuordnung zum prognostisch relativ günstigeren Typ C der NiemanfrPick-Eikrankung.
Introduction ination. There are, however, aspects of the diseases,
which so far can only be ascertained by use of radio-
For the diagnosis of lyspsomal disorders, acid hydrolases activejy Celled, natural substrates. Several of these
are measured, preferably in leukocytes, serum, cultured ^^^ substances> especially sphingolipids, can now be
skin-fibroblasts and sometimes also in urine. The sources urchasedj ̂  this leads to a simplification of the tests,
of these enzymes in prenatal diagnosis are native or
cultured amnion cells and amniotic fluid. Either the hydrophobic part of the sphmgolipid molecule
(e.g. by tritiation of the double-bond of sphingosine) (2),
In most cases synthetic chromogeriic (1) and fluoro- Qr fte hydrophilic part (3> 4> 6> 7) can be labelled. The
genie substrates are employed for the enzyme determ- ]atter type of labelling is found ^ one of the commerc-
') These studies are part of the thesis of/, Klenke (5). ially available sphingomyelins, where the 14C-marker is
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localized on the methyl-groups of the phosphorylcholine.
After the reaction has been accomplished, substrate
(sphingomyelin) and the reaction product phosphoryl-
choline can be separated by a simple jFbfcA-phase-distrib-
ution (6-8). Since often only minimum amounts of
enzyme are available, and because of radioactive hazards,
a micro-method seems most suitable.
In our laboratory a one-vial-method for Sphingomyelinase
determination with a good reproducibility was developed.
By means of this method Sphingomyelinase activity in
leukocytes and urine of healthy control persons has
been determined.
In addition, the urine of two normal persons was kept at
room temperature, and the amount of Sphingomyelinase




For the assay of the Sphingomyelinase activity in leukocytes,
blood samples were taken from healthy test persons (laboratory
personnel) of different age and sex. The urine of two students
(male 28 years, female 30 years) was collected daily over a
period of three weeks, and used for determination of the enzyme
excretion. The assay of the creatinine-clearance proved that
both test persons had no renal defect.
Leukocyte preparation
Chemicals: 25 000 USP-E heparin (e.g. 5 ml Liquemin) are added
to a solution of 25 g dextran (Sigma, Mr 200 000-275 000) and
3.5 g NaCl in 500 ml distilled water.
According to the method ofKampine (4), 5 ml venous blood
were collected in a syringe prepared with heparin. The blood
was added to a test tube, containing 1 ml of the above dextran
solution, carefully mixed, and kept at room temperature for
approx. 45-60 minutes. The overlay (plasma and leukocytes)
was removed and transferred to a pre-wejghed centrifuge tube.
After centrifugation (10 min at 2700 rpm) the overlay was
removed. The pellet contains leukocytes and some erythrocytes.
Red blood cells were removed by mixing the pellet with 5 ml
ice-cold distilled water, followed by the addition of 5 ml 17 g/1
NaCl solution. After repeated centrifugation the remaining
aqueous phase was discarded. The wet leukocytes were weighed,
and the leukocyte pellet combined with 6 vol. of distilled water.
The mixture was then homogenized, followed by addition of 2
vol. of solvent (containing distilled water and 2 mmol/1 of the
detergent taurodeoxycholate, TDC Sigma, in a ratio of 3 vol. +
1 vol). The protein content was determined by the method of
Lowry (9).
Examination of native urine
10 ml of a 24 h urine sample were filtered (filter paper). The
filtrate was adjusted to pH 5-6 with dilute acetic acid or
sodium hydroxide solution and dialyzed against distilled water
for 24 h at 4°C. The volume must be measured again after
dialysis. The creatinine contents of serum and urine were
determined with the Jaffe method (formation of a coloured
complex with picric acid), using a test kit (Boehringer Mann-
heim, Nr. 124 192).
Sphingomyelinase assay
370 kBq (ΙΟμΟί) of the commercially available sphingomyelin
(Amersham—Buchler) (specific activity 2220 GBq/mol
(60 mCi/mmol)), 14C-labelled in the methyl groups of the
choline part of the molecule, was diluted with 34 mg pure,
cold sphingomyelin (Mr 780) (Kochiight), and dissolved
in 50 ml benzene/ethanol 25 ml + 25 ml. The specific activity
was then 8736 MBq/mol (228 MCi/mmol). For the Sphingo-
myelinase assay 25 μΐ of the marked [14C)sphingqmyelin
(23 nmol) were transferred to an Eppendorf reaction vial, and
the solvent was evaporated. The residue was resuspended in
100 μΐ 2 g/l Triton X-100 in 0.1 mol/1 sodium acetate buffer
pH 5.0, using ultrasonic treatment; then 50 μΐ solvent (contain-
ing distilled water and 2 mmol/1 TDC in a ratio of 3 vol. + 1 vol.)
and 50 μΐ enzyme solution were added. The total volume of the
reaction mixture was 200 μΐ.
After incubation for 24 hours at 379C, the reaction was stopped
by adding 800 μΐ chloroform/methanol 200 nil + 100 ml. Two
phases in a ratio 1 vol. + 2 vol. were separated by centrifugation.
The aqueous upper phase contained the split phosphoryl [14C]
choline; the lower phase includes the unchanged [14C] sphingo-
myelin. Aliquots (150 μΐ of the upper phase and 300 μΐ of the
lower phase) are transferred to scintillation vials. The solvents
were evaporated under infrared light with a stream of nitrogen.
After addition of 15 ml of scintillator solution (Unisolve 1,
Koch-Light), the radioactivity was measured in a scintillation
counter (Packard, model Tricarb No. 2425).
Analysis
upper phase counts/min
upper phase counts/min + lower phase counts/min
Evaluation:
degraded fraction X 23 X 1000
= degraded fraction
24 X μg protein iri 50 μΐ leukocyte extract
= nmol/h · mg protein
degraded fraction X 23 X 20
24
= nrnpl/h · ml urine
Reference enzyme
α-glucosidase, as a reference enzyme with the fluorogenic
substrate ^methylumbeUiferol-a-glucopyranoside (Sigma), was
tested at the same time.
Results
For prior examination, increasing amounts of leukocyte
protein were added to test the relation between the
amount of hydrolyzed sphingomyelin and the amount of
enzyme added. Even with small amounts of protein, the
relation was nearly linear (fig. 1).
Batches of 100 μ% leukocyte protein were incubated for
different periods of time under the conditions indicated
above. Even for short incubation periods the relation was
linear (fig. 2).
In addition batches of 25 μΐ leukocyte extract (equi-
valent to ca. 40 Mg protein) were incubated with im
creasing amounts of substrate (9—110 nmol sphingo-
myelin). The amount of free phosphorylcholine was
constant. Substrate is actually required in excess for
the measurement of enzyme activity. A degradation
less than 0.005 was obtained with routinely performed
controls containing no, or heat-denaturated enzyme
protein.
Sphingomyelinase activity (mean value) in leukocytes
of 9 normal persons was 2.15 nmol/h · mg protein .
(standard deviation s = 0.35, coefficient of variation
CV = 16%), and (mean value x) 1.2 nmol/h - ml in
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Fig. l. Cleavage of C-sphingomyelin with various amounts
of leukocyte protein. Ordinate: amount of 14C-sphingo-
myelin hydrolyzed expressed as pmol/h. Abscissa:
amount of added protein [jug].
Further details see: Material and Methods.
urine (n = 50, s = 0.5, CV = 41.6%). The enzyme activ-
ities measured in urine were notably more scattered.
Therefore, the Sphingomyelinase activity in the urine
of two healthy test persons was measured over a period
of three weeks and related to the daily urine excretion,
the daily excretion of creatinine, and α-glucosidase as
reference enzyme for the 24-hour-urine. The mean value,
standard deviation, and coefficient of variation were
calculated from the daily determined relation coefficients
(tab. 1).
Furthermore, urine samples were tested daily for a
period of six days, to see whether storage of urine at
room temperature causes a decrease of activity. It
turned out that no significant decline of sphingomyelin-
t l h l
15
Fig. 2. Time-dependence of the cleavage of 14C-sphingomyelin.
Amount of C-sphingomyelin hydrolyzed expressed as
nmol after addition of 100 μg leukocyte protein as a
function of time.
Further details see: Material and Methods.
ase and α-glucosidase activity could be observed for the
undialyzed urine. Yet, from the third day on, dialyzed
urine samples showed a decrease to 30—0% of the
initial enzyme activity.
Discussion
The common method for the determination of Sphingo-
myelinase activity is based on the precipitation of
marked undegraded sphingomyelin with concentrated
trichloroacetic acid. Our method is based on the direct
phase separation of degraded water-soluble phosphoryl-
choline and water-insoluble sphingomyelin (6—8). This
method is not only more sensitive, but it also has a good
reproducibility of the degradation rates for the labelled
substrate. Deviation of the degradation rates was not
higher than 10% in simultaneous tests.
Our Sphingomyelinase activity in leukocytes is lower
than the values reported by Kampine (4) evaluated with
Tab. 1. Sphingomyelinase activity, α-glucosidase activity and creatinine excretion in urine (estimated daily for three weeks).
sphingomyelin se excretion in 24-h-urine
(sphingomyelin hydrolyzed [μήιοΙ/24 h · 24-h-urine])
Sphingomyelinase excretion in 244i-urine [μηιρΙ/24 h · 24-h-urine]
creatinine excretion in 244v=urine [g/24-hrurine]
α-glucosidase excretion in 24-h-urine (μιηοΐ/h · 24-h-urine]
sphiiigoniyelinase excretion in 24-h^unne [μιηοΙ/24 h · 24-h-urine]
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a different method (3.2-5.6 nmol/h · mg protein). Our
values, however, show a much lower scattering. They
are in the range of leukocyte protein values reported by
Gal et al. (2.2-3.7 nmol/h - mg protein) (1). However,
the latter authors regard [14C]sphingomyelin as the pre-
ferred substrate for sphingomyelinase assays in leuko-
cyte preparations, owing to the poor degradation rate of
their chromogenic substrate (2-hexadecanoylamino-4-
nitrophenylphosphorylcholine) by leukocyte protein.
Problems of enzyme measurements in urine are well
known (11). To our knowledge, there are no represent-
ative investigations on sphingomyelinase activities in
urine. The range of the values is higher for urine than
for leukocytes. It has been shown that the meas-
urable enzyme activities in the urine can be most
directly correlated to the 24-hour creatinine excretion
(11).
For screening of sphingomyelinase deficiency in urine
the stability of the enzyme is of great importance,
because the material is often sent through the post. In
fact, there will be no important loss of enzyme activity.
α-glucosidase, as a reference enzyme, was measured
every day in the urine of the two persons over a period
of three weeks. This enzyme has a higher degree of
scattering than sphingomyelinase. In spite of this fact
1—2 reference enzymes should be tested simultan-
eously to eliminate interfering artefacts (bacterial
influence, medication). Our finding, that within 6 days
no significant decrease of the enzyme activity in the
undialyzed urine was observed, is of great practical
importance. However, the dialyzed urine always showed
nearly a complete decrease of the measurable activity,
beginning at about the third day of dialysis. This may
result from the loss of ions caused by dialysis.
Test results of numerous authors indicate that the
actual enzyme deficiencies in vivo are more reliably
reflected, if natural instead of synthetic substrates are
used. In addition the employment of radioactively
labelled natural substrate allows a microscale assay
that requires only small amounts of enzyme. This may
be important for pediatric examinations, family tests,
or for prenatal diagnosis.
In a family (family F. from East-Frisia) two out of
three children both starting with the third year of age
showed mental retardation and neurological deterior-
ation combined with hepatosplenomegaly. The light
microscopic and electronic optical examination of
bone marrow and rectal mucous membrane obtained by
biopsy revealed a typical picture of sphingomyelin
storage disease for the examined second child. Both
children are still alive. They are now five and seven
years old. However, no decrease in sphingomyelinase
activity was found in leukocytes and urine for any
member of the family (tab. 2). Based on the classific-
ation of sphingomyelinoses according to biochemical
and clinical criteria proposed by Frederickson et al.
(10), the mentioned cases can be related to type C
Niemann-Pick disease. That type is the one with the
mildest course of storage disease and therefore it has a
relatively favourable prognosis.
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Tab. 2. Sphingomyelinase activity in human leukocytes and urine (Control persons and one family with Niemann-Pick disease).
Control persons














































+) sphingomyelin hydrolyzed [nmol/h · mg proteinj
; sphingomyelin hydrolyzed [nmol/h · ml dialyzed urine]
+H) Compared to the first child these two children were affected by hepatosplenomegaly, mental retardation, and neurological
deterioration starting with the third year of age.
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